Strengthen your portfolio by making more informed decisions and prepare for the impact of new research discoveries.


One source, many insights
MIDAS® has long been considered the gold standard in market information. Integrating the breadth and depth of IQVIA's unparalleled data assets with advanced analytics and deep domain expertise, MIDAS helps you confidently
- Track corporate performance globally
- Understand your main competitors at a therapy and country level
- Identify analogues to apply to your analysis
- Learn how your competitors are performing
- Identify and target new markets for licensing and development
- Understand usage of your product across countries – by formulation and indication
- Track prescribing information across countries
With MIDAS Disease, add a disease dimension to your market analyses. Leveraging IQVIA MIDAS, hyper-segment your market and your competitive landscape by 600 diseases and 35 tumors. This will empower better data driven decision making to achieve continual business growth.
Dig deeper, identify new opportunity
Beyond product-level information, MIDAS can reveal trends at the level you need to proactively segment your market and prioritize new opportunities. Additional views include
- Therapy areas
- Manufacturers
- Currencies
- Formulation and ingredients
- Innovative Brands and Generics
Related solutions
Measure the performance of your sales force and marketing channels, adapt your commercial strategy and gain real world competitive insights.
Access 470,000 products and nearly 40,000 drug profiles to analyze successful launch strategies and be ready for what’s next.
Track more than 60,000 pharmaceutical patent families across 130 countries to find opportunities and ensure timely business decisions.
